Watchlist Price Alert

Quince Therapeutics Inc. (QNCX)

NASDAQ: QNCX · Real-Time Price · USD

1.06

-0.02 (-1.85%)

At close: May 02, 2025, 3:57 PM

1.09

2.83%

After-hours: May 02, 2025, 04:41 PM EDT

Quince Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-56.83M	-31.39M	-51.66M	-89.94M	-76.85M	-36.98M	-12.48M	-12.23M
Depreciation & Amortization	186K	322K	204K	344K	332K	188K	51K	45K
Stock-Based Compensation	4.75M	5.22M	16.62M	29.85M	14.47M	2.06M	155K	38K
Other Working Capital	-1.41M	2.27M	-3.89M	-5.62M	9.75M	-676K	-367K	237K
Other Non-Cash Items	20.48M	5.82M	913K	199K	367K	367K	1.11M	1.64M
Deferred Income Tax	n/a	-248K	-284K	878K	635K	-812K	-145K	222K
Change in Working Capital	-484K	1.98M	-9.83M	-4.26M	10.23M	1.9M	-390K	460K
Operating Cash Flow	-31.9M	-18.29M	-44.04M	-62.93M	-50.82M	-33.28M	-11.7M	-9.83M
Capital Expenditures	-257K	-160K	-133K	-180K	-52K	-55K	-212K	-77K
Cash Acquisitions	n/a	-2.12M	10.59M	-58.95M	52.43M	-812K	n/a	n/a
Purchase of Investments	-89.56M	-113.78M	-75.02M	-38.79M	-187.14M	-135.41M	-55.24M	n/a
Sales Maturities Of Investments	109.38M	111.21M	82.49M	97.92M	134.76M	117.72M	8.7M	n/a
Other Investing Acitivies	2.35M	-910K	70K	58.95M	-52.43M	812K	-46.54M	n/a
Investing Cash Flow	21.91M	-5.76M	18M	58.95M	-52.43M	-17.75M	-46.75M	-77K
Debt Repayment	n/a	-6K	-49K	n/a	-34K	-559K	250K	7.75M
Common Stock Repurchased	n/a	63.73M	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-4.78M	149K	148K	6.81M	1.28M	98K	-10K	n/a
Financial Cash Flow	-4.78M	143K	707K	6.81M	118.88M	77.37M	75.93M	7.75M
Net Cash Flow	-14.54M	-23.83M	-25.14M	2.88M	15.63M	26.34M	17.48M	-2.15M
Free Cash Flow	-32.16M	-18.45M	-44.17M	-63.11M	-50.87M	-33.33M	-11.91M	-9.9M